229500 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
NovMetaPharma Co., Ltd. engages in the manufacture and sale of biological drugs for insulin resistance and related metabolic diseases. Its business areas include new medicine development and healthy foods. Its products include medicines for diabetes, obesity, Alzheimer's disease, immunity cure, osteoporosis, and non-alcoholic fatty liver. The company was founded on November 4, 2010 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
229500 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company